Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

162 questions in 21 reviews · cluster CL0190

current versions
No studies 28 · 17.3%Ungraded 98 · 60.5%Very low 27 · 16.7%Low 9 · 5.6%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Intervention categories, outcome domains and clusters are a proposed key pending human validation. Clear all filters

QuestionEffectEvidenceStatus / GRADE
Er:YAG laser surface debridement before bone augmentation vs Plastic curettes plus saline solution before bone augmentation
Implant failure · People with at least one dental implant affected by peri-implantitis · 6 months
Interventions for replacing missing teeth: treatment of peri‐implantitis (2012) · Cochrane
Six months after treatment there were no implant failures.1 study · 30 participantsUngraded
Er:YAG laser surface debridement before bone augmentation vs Plastic curettes plus saline solution before bone augmentation
Change in probing pocket depth (PPD reduction) · People with at least one dental implant affected by peri-implantitis · 6 months
Interventions for replacing missing teeth: treatment of peri‐implantitis (2012) · Cochrane
Six months after treatment there were no statistically significant differences for PPD reduction.1 study · 30 participantsUngraded
Er:YAG laser surface debridement before bone augmentation vs Plastic curettes plus saline solution before bone augmentation
Change in soft tissue recession (REC) · People with at least one dental implant affected by peri-implantitis · 6 months
Interventions for replacing missing teeth: treatment of peri‐implantitis (2012) · Cochrane
Six months after treatment there were no statistically significant differences for soft tissue recessions.1 study · 30 participantsUngraded
Er:YAG laser debridement vs Manual debridement plus chlorhexidine irrigation/gel
Recurrence of peri-implantitis · People with at least one dental implant affected by peri-implantitis · 6 months
Interventions for replacing missing teeth: treatment of peri‐implantitis (2012) · Cochrane
RR 0.25 [0.03, 2.06]2 studies · 40 participantsUngraded
Er:YAG laser debridement vs Manual debridement plus chlorhexidine irrigation/gel
Change in probing pocket depth (PPD) · People with at least one dental implant affected by peri-implantitis · 6 months
Interventions for replacing missing teeth: treatment of peri‐implantitis (2012) · Cochrane
No statistically significant differences for change in PPD.1 study · 20 participantsUngraded
Erbium:YAG laser (implant exposure) vs Flap elevation at implant exposure
Biological complications · Patients undergoing implant exposure (second-stage surgery)
Interventions for replacing missing teeth: management of soft tissues for dental implants (2012) · Cochrane
RR 3.0 [0.14, 65.90]1 study · 20 participantsUngraded
Laser (low level) vs Placebo/sham/no treatment
Oral mucositis (any severity) · Patients with cancer receiving radiotherapy, chemotherapy or targeted therapies · Median 28 days
Interventions for preventing oral mucositis for patients with cancer receiving treatment (2011) · Cochrane
RR 0.91 [0.71, 1.17]5 studies · 234 participantsUngraded
Laser (low level) vs Placebo/sham/no treatment
Oral mucositis (moderate to severe) · Patients with cancer receiving radiotherapy, chemotherapy or targeted therapies · Median 28 days
Interventions for preventing oral mucositis for patients with cancer receiving treatment (2011) · Cochrane
RR 0.64 [0.38, 1.08]2 studiesUngraded
Laser (low level) vs Povidone
Oral mucositis (moderate to severe) · Patients with cancer receiving radiotherapy, chemotherapy or targeted therapies · Median 28 days
Interventions for preventing oral mucositis for patients with cancer receiving treatment (2011) · Cochrane
RR 0.29 [0.16, 0.54]1 study · 50 participantsUngraded
Laser (low level) vs Placebo/sham/no treatment
Oral mucositis (severe) · Patients with cancer receiving radiotherapy, chemotherapy or targeted therapies · Median 28 days
Interventions for preventing oral mucositis for patients with cancer receiving treatment (2011) · Cochrane
RR 0.2 [0.06, 0.62]2 studiesUngraded
Laser (low level) vs Povidone
Oral mucositis (severe) · Patients with cancer receiving radiotherapy, chemotherapy or targeted therapies · Median 28 days
Interventions for preventing oral mucositis for patients with cancer receiving treatment (2011) · Cochrane
RR 0.02 [0, 0.31]1 study · 50 participantsUngraded
Low level laser therapy vs Sham (placebo) laser treatment
Mucositis severity (mild to moderate) · People with cancer receiving chemotherapy or radiotherapy (or both) who have oral mucositis
Interventions for treating oral mucositis for patients with cancer receiving treatment (2010) · Cochrane
RR 5.28 [2.30, 12.13]2 studies · 57 participantsUngraded